Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies

Virchows Archiv

Volumn 446, Issue 4, 2005, Pages 369-378

  Herpel, E ^a   Singer, S ^a   Flechtenmacher, C ^a   Pritsch, M ^a   Sack, F U ^a   Hagl, S ^a   Katus, H A ^b   Haass, M ^b   Otto, H F ^a   Schnabel, P A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b University of Heidelberg ^*

Author keywords

Cardiomyopathies; Extracellular matrix; Left ventricle; Remodeling; Right ventricle

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LAMININ; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

ARTICLE; CARDIOMYOPATHY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONNECTIVE TISSUE; CONTROLLED STUDY; EVALUATION; EXPLANT; EXTRACELLULAR MATRIX; FROZEN SECTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAINING; STATISTICAL SIGNIFICANCE;

CARDIOMYOPATHY, DILATED; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VENTRICULAR REMODELING;

EID: 21044454553     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1177-z     Document Type: Article

References (37)

1. Adler CP, Neuburger M, Herget GW, Mühlbach D (1997) Regeneration processes in human myocardium after acute ischaemia-quantitative determination of DNA, cell number and collagen content. Virchows Arch 430:149-153
2. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P (1994) Myocardial function/valvular heart disease/hypertensive heart disease: structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89:151-163
3. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P (1995) The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 27:291-305
4. Birkdal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
5. Bosman FT, Stamenkovic I (2003) Functional structure and composition of the extracellular matrix. J Pathol 200:423-428
6. Coker ML, Doscher MA, Thomas ChV, Galis ZS, Spinale FG (1999) Matrix metalloproteinase synthesis and expression in isolated myocyte preparations. Am J Physiol Heart Circ Physiol 277:777-787
7. Coker ML, Zellner JL, Crumbley AJ, Spinale FG (1999) Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy. Ann N Y Acad Sci 878:559-562
8. Corradi D, Callegari S, Benussi S, Nascimbene S, Pastori P, Calvi S, Maestri R, Astorri E, Pappone C, Alfieri O (2004) Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery. Virchows Archiv 445:498-505
9. Diez J (2002) Emerging role of matrix metalloproteinases in the pathophysiology of cardiac diseases. Eur J Clin Invest 32:291-294
10. Feldman AM, Li YY, McTiernan CF (2001) Matrix metalloproteinases in pathophysiology and treatment of heart failure. Lancet 357:654-655
11. Florholmen G, Andersson KB, Yndestad A, Austbø B, Henriksen UL, Christensen G (2004) Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism. Acta Physiol Scan 180:133-142
12. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin. Science 277:225-228
13. Gunderson HJG, Osterby R (1981) Optimizing sampling efficiency of stereological studies in biology or "Do more less well!" J Microscopy 121:65-73
14. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ (2003) The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 200:516-525
15. Ishikawa Y, Asuwa N, Ishii T, Ito K, Akasaka Y, Masuda T, Zhang L, Kiguchi H (2000) Collagen alteration in vascular remodeling by hemodynamic factors. Virchows Arch 437:138-148
16. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG, Glogar HD (1995) Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75:913-918
17. Li YY, Feldman AM, Sun Y, McTiernan CF (1998) Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98:1728-1734
18. Li YY, McTiernan CF, Feldman AM (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46:214-224
19. Lu L, Gunja-Smith Z, Woessner JF, Ursell PC, Nissen T, Galardy RE, Xu Y, Zhu P, Schwartz GG (2000) Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am J Physiol Heart Circ Physiol 279:601-609
20. Mundhenke M, Schwartzkopff B, Strauer B (1997) Structural analysis of arteriolar and myocardial remodelling in the sub-endocardial region of patients with hypertensive disease and hypertrophic cardiomyopathy. Virchows Arch 431:265-273
21. Nogami K, Kusachi S, Nunoyama H, Kondo J, Endo C, Yamamoto K, Murakami T, Tsuji T (1996) Extracellular matrix components in dilated cardiomyopathy. Jpn Heart J 37:483-494
22. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kuhl U, Schultheiss HP (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99:2750-2756
23. Pauschinger M, Chandrasekharan K, Li J, Schwimmbeck PL, Noutsias M, Schultheiss HP (2002) Remodeling der extrazellulären Matrix bei dilatativer Kardiomyopathie. Herz 27:677-682
24. Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR (2002) Cardiac remodelling in end stage heart failure: up-regulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart 88:525-530
25. Rossi MA (1991) Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy. Can J Cardiol 7:287-294
26. Rossi MA (1998) Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertension 16:1031-1041
27. Rossi MA, Abreu MA, Santoro LS (1998) Connective tissue skeleton of the human heart. A deminstration by cell-maceration scanning electron microscope methode. Circulation 97:934-935
28. Sandmann S, Bohle RM, Dreyer T, Unger T (2000) The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Virchows Arch 436:147-157
29. Schaper J, Speiser B (1992) The extracellular matrix in the failing human heart. Basic Res Cardiol 87[Suppl]:303-309
30. Soini Y, Satta J, Määttä M, Autio-Harmainen H (2001) Expression of MMP-2, MMP-9, MT1-MMP, TIMP-1 and TIMP-2 mRNA in valvular lesions of the heart. J Pathol 194:225-231
31. Spinale FG (2002) Matrix metalloproteinases. Regulation and dysregulation in the failing heart. Circ Res 90:520-530
32. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464
33. Tyagi SC (1997) Proteinases and myocardial extracellular matrix turnover. Moll Cell Biochem 168:1-12
34. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ (1996) Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 155:13-21
35. Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BV, Thompson ME, Leier CV (1986) Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol 57:816-820
36. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JRB, Sawicki G, Schulz R (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion in injury. Circulation 106:1543-1549
37. Weibel ER (ed) (1979) Stereological methods, vol. 1. Practical methods for biological morphometry, 1st edn. Academic Press, London, pp 101-161